Related Experiment Videos
MTP-PE: induction of tumoricidal leukocytes in the lungs of rats
1Research Department, Ciba-Geigy Limited, Basel, Switzerland.
Abstract:
Buffer solubilized MTP-PE binds very quickly (within 10 min) to rat alveolar macrophages in vitro and activates them to the tumoricidal state. In vivo, the alveolar macrophages become tumoricidal after intratracheal instillation of MTP-PE. Intranasal application of a relatively large volume (300 microliter) gives the same result, because MTP-PE is then aspirated into the lungs. A wide dose range (1-10,000 micrograms/kg) is effective. Immediately after application of MTP-PE, activated macrophages can be washed out of the lungs. Between 8 and 48 hr after application many tumoricidal neutrophils are also found. Although the tumoricidal activity decreases with time, it can still be demonstrated 8 days after application. Intravenous injection is also effective, but only at 10(3)-fold higher doses. Inhalation of MTP-PE might be of therapeutical value in the treatment of cancer, particularly in the lungs.
Insights
Muramyl tripeptide-phosphatidylethanolamine (MTP-PE) rapidly activates rat alveolar macrophages to a tumoricidal state, both in vitro and in vivo. This immunotherapy shows potential for lung cancer treatment via inhalation.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Alveolar macrophages play a crucial role in lung immunity.
- Tumoricidal activity of immune cells is a key mechanism in cancer therapy.
Purpose of the Study:
- To investigate the efficacy of MTP-PE in activating macrophages for tumoricidal functions.
- To evaluate MTP-PE as a potential therapeutic agent for lung cancer.
Main Methods:
- In vitro studies using rat alveolar macrophages.
- In vivo studies involving intratracheal and intranasal administration of MTP-PE in rats.
- Assessment of macrophage and neutrophil tumoricidal activity over time.
Main Results:
- MTP-PE rapidly induced tumoricidal activity in alveolar macrophages in vitro and in vivo.
- Intratracheal and intranasal MTP-PE effectively activated macrophages, with a broad effective dose range.
- Tumoricidal neutrophils were also observed, and activity persisted for up to 8 days.
- Intravenous administration required significantly higher doses for efficacy.
Conclusions:
- Inhalation of MTP-PE is an effective method for activating tumoricidal immune cells in the lungs.
- MTP-PE demonstrates therapeutic potential for treating lung cancer through immune activation.